News Focus
News Focus
icon url

Amatuer17

11/24/14 6:56 PM

#79512 RE: TheDane #79510

Dane - good point -
If you check OTC - CTIX Moved to pink on 29th Oct - just 2 weeks before 1st big PR on 11-11
After Oct 29th we have not touched 1 million volume any day

Next 2 weeks will tell whether pink had serious impact on our price movement. It had impact in my opinion.

icon url

scgmck1

11/24/14 6:57 PM

#79513 RE: TheDane #79510

TD,
Most threads on this board involve a lot of speculation, and I try to abstain. Speculatively speaking though, I can't help but think that we would be trading higher if not for our "pink" status at present. You're correct, that I can't know for sure. Probably more tactical on Leo's part....will the pleasure be worth all the pain? I guess we'll find out soon enough.
icon url

Tails

11/24/14 7:02 PM

#79515 RE: TheDane #79510

TD,
I think Leo is NOT in the business of uplisting prior to some definitive results (B p2b, or K actual data). Since he knows both of those are right around the corner he is waiting to give us results and uplisting as a coordinated event... think ASM (1st qtr 2015?).
Leo is at the controls and knows these waters well.

Recall his comment from 2012 R&R regarding Kevetrin:

Two quotes from Leo's presentation at Rodman 9/11/12:

1. "Kevetrin is thoroughly protected through pending patents which cover tens of thousands of possible future chemical combinations for new drugs, a potentially very valuable proposition for multiple drug developments in the future."

2. ". I’m convinced beyond a doubt if we are able to see in the clinical trials even a portion of the results that we’ve seen in the lab studies, Cellceutix will experience a wave of unprecedented growth. "


Add to that his recent comments on B and I don't see how the current lack of uplisting is of concern.

I believe CTIX has already seen more than a "portion" of the K lab results.....

Go CTIX!